OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2021-04-30-accounts

Page
Report ofthe Trustees I to 4
Independent
Examiner's
Report
Statentent ofFinancial Activities
Balance Sheet 7 to 8
Notes to the Financial Statements 9 to 17
Detailed Statement ofFinancial Activities 18 to 19

f r th
Y
rE
n
3
A ril2
21
30.4.21 30.4.20
Unrestricted Restricted Total Total
funds funds funds fUll(IS
Notes f,
INCOME AND ENDOWMENTS FROM
Donations
and legacies
2 63,830 16,839 80,669 130,553
Other trading activities 3 30,512 55 30,567 157,623
Investnient
income
4 1,720 1,720 3,037
Total 96,062 16,894 112,956 291,213
EXPENDITURE ON
Raising funds 66,184 166 66,350 129,625
Charitable
activities
Expenditure
on Charitable
Activities 44,115 24,119 68,234 176,394
Total 110,299 24,285 134,584 306,019
Net gauls/(losses)
on investments
55,783 55,783 (3,212)
NET INCOME/(EXPENDITURE) 41,546 (7,391) 34,155 (18,018)
Transfers
behveen
funds
14 20,578 (20,578)
Net movement
in fnnds
62,124 (27,969) 34,155 (18,018)
RECONCILIATION
OF
FUNDS
Total funds brought
forward
77,514 202,308 279,822 297,840
TOTAL FUNDS CARRIED FORWARD 139,638 174,339 313,977 279,822

Ki
n
s
ForLif
~Bala cnSImt
30A 12 21
30.4.21 30.4.20
Unrestricted Restricted Total Total
funds funds funds funds
Notes f,
FIXEDASSETS
Inveshnents 10 136,480 162,858 299,338 290,160
CURRENT ASSETS
Stocks ll 1,533 1,533
Debtors 12 6,146 461 6,607 4,810
Cash at bank and in hand 17,690 17,639 35,329 75,643
25,369 18,100 43,469 80,453
CREDITORS
Amounts
falling due within one year
13 (22,211) (6,619) (28,830) (90,791)
NET CURRENT ASSETS 3, 158 11,481 14,639 (10,338)
TOTAL ASSETSLESSCURRENT
LIABILITIES 139,638 174,339 313,977 279,822
NET ASSETS 139,638 174,339 313,977 279,822
FUNDS 14
Unrestricted
funds:
General
fund
90,620 74,438
Revaluation
Fund
49,018 3,076
139,638 77,514
Restricted funds:
Children's
Renal Fund
36,443 23,320
Bladder Exstrophy
Fund
Grants Awarded Not Yet Taken
3,427
126,292
173,698
Kidney Info Network
Urology Sports Day
Tameside Dialysis
Adult Transplant
Games
Polycystic kidney disease research
285
3,792
1,102
1,000
1,998
401
3,912
977
174,339 202,308
TOTALFUNDS 313,977 279,822

30.4.21 30.4.20
80,669 130,553

30.4.21 30.4.20
Fundraising events 30,567 157,623

for the Year En
e
for the Year En
e
3
A rll 2021
4, INVESTMENT INCOME
30.4.21 30.4.20
Dividend and stock income 1,706 2,979
Deposit account interest 14 58
1,720 3,037

30.4.21 30.4.20
Professor Titus Augustine 800
Dr Smeeta Sinha 800
1,600
STAFFCOSTS
The average monthly number ofemployees during the year ivas as folloivs:
30.4.21 30.4.20
I 2
No employees
received emoluments
in excess off60,000.
COMPARATIVES FOR THE STATEMENT OFFINANCIAL ACTIVITIES
Unrestricted Restricted Total
funds funds funds
f,
INCOME AND ENDOWMENTS FROM
Donations
and legacies
118,996 11,557 130,553
Other trading activities 142,078 15,545 157,623
Investment
income
3,036 1 3,037
Total 264,110 27,103 291,213
EXPENDITURE ON
Raising funds 129,525 100 129,625
Charitable
activities
Expenditure
on Charitable
Activities 94,278 82,116 176,394

COMPARATIVES FOR THE STATEMENT COMPARATIVES FOR THE STATEMENT OFFINANCIAL ACTIVITIES -continued ACTIVITIES -continued
Unrestricted Restricted Total
funds funds funds
Total 223,803 82,216 306,019
Net gahis/(losses)
on investments
(3,212) (3,212)
NET INCOME/(EXPENDITURE) 37,095 (55,113) (18,018)
Transfers
behveen
funds
(70,730) 70,730
Net movement
in fuuds
(33,635) 15,617 (18,018)
RECONCILIATION OFFUNDS
Total funds brought
forward
111,149 ]86,691 297,840
TOTAL FUNDS CARRIED FORWARD 77,514 202,308 279,822
8, NET GAINS/(LOSSES) ON INVKSTMKNTS
Realised net gains on inveshnents 30.4.21 30.4.20
f,
Share dealing - gains 14,428 3,127
Share dealing - losses (4,581) (3,697)
9,847 (570)
Unrealised
gain/(loss)
on
revaluation 45,936 (2,642)
55,783 (3,212)
Realised net losses/gains are stated aRer deducting dealing charges.
Total transaction
charges
for the year are as follows: f
Dealing charges 480 287
TANGIBLE FIXEDASSETS
Office Computer
equipment equipment Totals
f, g
COST
At
1 May 2020 and 30Apri12021
1,518 13,535 15,053
DEPRECIATION
At
1 May 2020 and 30April 2021
1,518 13,535 15,053
NKT BOOK VALUE
At 30April 2021
At 30April 2020

STOCKS
30,4,21 30.4.20
Finished goods 1,533
DEBTORS:AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.21 30.4.20
Other debtors 2,017 4,234
Provision for tax rebate 2,446
Prepayments 2,144 576
6,607 4,810
CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.21 30.4.20
Trade creditors 20,229
Taxation and social security 171
Other creditors 8,430 90,791
28,830 90,791
MOVEMENT IN FUNDS
Net Transfers
movement between At
At 1.5.20 in funds funds 30xk21
8 8
Unrestricted
funds
General fund 74,438 (326) 16,508 90,620
Revaluation
Fund
3,076 45,936 6 49,018
Designated
Fund
(4,064) 4,064
77,514 41,546 20,578 139,638
Rnstricted
funds
Children's
Renal Fund
23,320 13,123 36,443
Bladder Exstrophy Fund 421 3,006 3,427
Grants Awarded Not Yet Taken 173,698 (23,822) (23,584) 126,292
Kidney Info Network 401 (116) 285
Urology Sports Day 3,912 (120) 3,792
Tameside Dialysis 977 125 1,102
Adult Transplant Games 1,000 1,000
Polycystic kidney disease research 1,998 1,998
202,308 (7,391) (20,578) 174,339
TOTAL FUNDS 279,822 34,155 313,977

Incoming Resources Gains and Movement
resources expended losses in funds
f, f
Unrestricted
funds
General
fund
96,062 (106,235) 9,847 (326)
Revaluation
Fund
45,936 45,936
Designated
Fund
(4,064) (4,064)
96,062 (110,299) 55,783 41,546
Restricted
funds
Children's
Renal Fund
13,348 (225) 13,123
Bladder Exstrophy Fund 421 421
Grants Awarded Not Yet Taken (23,822) (23,822)
Kidney Info Network (116) (116)
Urology Sports Day (120) (120)
Tameside Dialysis 125 125
Adult Transplant Gmnes 1,000 1,000
Polycystic kidney disease research 2,000 (2) 1,998
16,894 (24,285) (7,391)
TOTAL FUNDS 112,956 (134,584) 55,783 34,155
Comparatives
for
movement in funds
Net Tmnsfers
movement between At
At 1.5.19 in funds funds 30.4.20
6
Unrestricted
funds
General fund 79,446 81,874 (86,882) 74,438
Revaluation
Fund
6,771 (2,642) (1,053) 3,076
Designated
Fund
24,932 (42,137) 17,205
111,149 37,095 (70,730) 77,514
Restricted
funds
Children's
Renal Fund
29,247 (5,927) 23,320
Bladder Exstrophy Fund 16,818 (4,062) (12,756)
Grants Awarded
Not Yet Taken
140,126 (49,914) 83,486 173,698
Kidney Info Network 500 (99) 401
Urology Sports Day 3,912 3,912
Tameside Dialysis 977 977
186,691 (55,113) 70,730 202,308
TOTAL FUNDS 297,840 (18,018) 279,822

Illcollllllg Resources Gahts and Movement
resources expended losses in funds
f, f. g
Unrestricted
funds
Geneml
fund
264,110 (181,666) (570) 81,874
Revaluation
Fund
(2,642) (2,642)
Designated
Fund
(42,137) (42,137)
264,110 (223,803) (3,212) 37,095
Restricted
funds
Children's
Renal Fund
20,535 (26,462) (5,927)
Bladder Exstrophy Fund 590 (4,652) (4,062)
Grants Awarded
Not Yet
Taken (49,914) (49,914)
Kidney Info Network I (100) (99)
Urology Sports Day 5,000 (1,088) 3,912
Tameside Dialysis 977 977
27,103 (82,216) (55,113)
TOTAL FUNDS 291,213 (306,0]9) (3,212) (18,018)
A current year 12 months and prior year 12months combined position is as follows:
Net Transfers
movement between At
At 1.5.19 in funds funds 30.4.21
f,
Unrestricted
funds
General
fund
79,446 81,548 (70,374) 90,620
Revaluation
Fund
6,771 43,294 (1,047) 49,018
Designated
Fund
24,932 (46,201) 21,269
111,149 78,641 (50,152) 139,638
Restricted
funds
Children's
Renal Fund
29,247 7,196 36,443
Bladder Exstrophy Fund 16,818 (3,641) (9,750) 3,427
Grants Awarded Not Yet Taken 140,126 (73,736) 59,902 126,292
Kidney Info Nehvork 500 (215) 285
Urology Sports Day 3,792 3,792
Tameside Dialysis 1,102 1,102
Adult Transplant
Games
1,000 1,000
Polycystic kidney disease research 1,998 1,998
186,691 (62,504) 50,152 174,339
TOTAL FUNDS 297,840 16,137 313,977

Inconiing Resources Gains and Movement
resources expended losses in funds
f.
Unrestricted
funds
General
fund
360,172 (287,901) 9,277 81,548
Revaluation
Fund
43,294 43,294
Designated
Fund
(46,201) (46,201)
360,172 (334,102) 52,571 78,641
Restricted
funds
Children's
Renal Fund
33,883 (26,687) 7,196
Bladder Exstrophy Fund 1,011 (4,652) (3,641)
Grants Awarded Not YetTaken (73,736) (73,736)
Kidney Info Network I (216) (215)
Urology Sports Day 5,000 (1,208) 3,792
Tameside Dialysis 1,102 1,102
Adult Transplant Games 1,000 1,000
Polycystic kidney disease research 2,000 (2) 1,998
43,997 (106,501) (62,504)
TOTAL FUNDS 404,169 (440,603) 52,571 16,137

Balance at Balance at
1.5.20 Incoming Outgolllg 30.4.21
Movement to date 68,034 17 6,267 61,784

~Kid
F
i.ii
m fFin nci IActivities
f r h Ye rEn ed 30A ril2021
30.4.21 30.4.20
INCOME AND ENDOWMENTS
Donations
and legacies
Donations 80,669 130,553
Other trading
activities
Fundraising
events
30,567 157,623
Investnientincome
Dividend
and stock
income 1,706 2,979
Deposit account interest 14 58
1,720 3,037
Total incoming
resources
112,956 291,213
EXPENDITURE
Raising donations and legacies
Wages 48,169 75,556
Postage and miscellaneous 4, 111 2,844
Promotional
costs
5,877 8,449
Event costs 4, 198 37,285
Travel costs 270 1,002
Card fees 961 2,946
Christmas
cards
2,764 1,543
66,350 129,625
Charitable
activities
Grant management 16,502 25,375
Bladder Exstrophy
Fund
4,652
Children's
Renal Fund (formerly
Childrens
Transplant
Games)
26,462
Miscellaneous
grants
3,535 11,417
Ward and medical equipment 100 13
Travel k conference bursaries 16,216
Books and jounials 139
Small research grants 23,822 49,914
Nurse education 300 2,994
Patient support 310 11,358
Publication
grants
1,110
Urology Sports Day 1,088
44,569 150,738

for
he Year Ended 30A
ril2021
30.4.21 30.4.20
Support costs
Governance
costs
Governance
management
11,787 12,749
Insurance 677 651
Telephone 1,168 928
Accountancy 2,870 3,006
Inveshnent
management
2,789 2,914
Oftice Equipment
&Computer
Mahitenance
and Updates 4,374 5,408
23,665 25,656
Total resources expended 134,584 306,019
Net expenditure
before gains and losses
(21,628) (14,806)
Realised recognised
gains
and losses
Realised gains/(losses)
on
fixed asset investments 9,847 (570)
Profit/(loss)
on revaluation
ofinvestments 45,936 (2,642)
Net income/(expenditure) 34,155 (18,018)